A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis
Status:
Completed
Trial end date:
2017-08-28
Target enrollment:
Participant gender:
Summary
This pilot, multicentric and observational study will assess the safety of sulfamethoxazole +
trimethoprim + guaifenesin (Balsamic Bactrim) in pediatric participants with acute
bronchitis. Administration of treatment will be according to treating physician's
recommendation under local labeling.
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Guaifenesin Phenylpropanolamine Sulfamethoxazole Trimethoprim Trimethoprim, Sulfamethoxazole Drug Combination